Stay updated on Magrolimab Combo in Untreated MDS: Clinical Trial

Sign up to get notified when there's something new on the Magrolimab Combo in Untreated MDS: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab Combo in Untreated MDS: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The core study information (design, endpoints, eligibility, and outcomes) appears unchanged; differences observed are limited to page layout and display elements. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T20:41:32.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    2%
    Check dated 2025-10-06T05:11:51.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Added revision tag v3.1.0 and removed several drug-safety subsections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); versioning indicates a content update with potential consolidation of drug-safety topics.
    Difference
    0.2%
    Check dated 2025-09-29T02:58:32.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed; no other substantive changes detected.
    Difference
    0.1%
    Check dated 2025-09-14T18:58:33.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T14:18:06.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of a new facility name and location details, as well as a comprehensive list of publications related to a specific clinical study. Notably, the drug azacitidine has been retained in the context of myelodysplastic syndromes, while previous location details have been removed.
    Difference
    6%
    Check dated 2025-08-31T11:40:02.000Z thumbnail image

Stay in the know with updates to Magrolimab Combo in Untreated MDS: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in Untreated MDS: Clinical Trial page.